srch

27.01.2022 · News stories and articles referencing Biopharma on European Pharmaceutical Review. Recommended. Formulate live biotherapeutic products to enhance their effects [PODCAST] Oral biologic drug delivery with Giovanni Traverso, MIT. How the global chromatography systems market will evolve post-COVID-19.

Latest news for pharmaceuticals, biotechnology and life sciences. ... Biotech and Pharma. Health · Hospitals · Biotech and Pharma · Health Insurance ...

Breaking news from the biotech, clinical research and pharmaceutical industries. BioSpace is The Home of the Life Sciences Industry.

07.01.2022 · BOCA RATON, Fla., Jan. 07, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that it has further adjourned its Annual Meeting of …

Jan 06, 2022 · BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

06.01.2022 · BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

Jan 28, 2022 · Breaking news from the biotech, clinical research and pharmaceutical industries. BioSpace is The Home of the Life Sciences Industry.

Labiotech.eu is the leading digital media covering the European Biotech industry, read by 150000+ monthly visitors. Hope you'll enjoy our Biotech News!

03.01.2022 · Xeris Biopharma to raise $30M in private placement offering. Xeris Biopharma (NASDAQ: XERS) trades 2.1% higher premarket a fter it entered into a securities purchase agreement related to a private ...

BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development ...

Jan 27, 2022 · news New studies look to assess immunogenicity of Omicron-based vaccines. 27 January 2022 | By European Pharmaceutical Review. A new clinical study by Pfizer Inc. and BioNTech SE, and Phase II study by Moderna, are seeking to evaluate the immunogenicity and safety of Omicron-based vaccines and boosters.

2 dager siden · ENDPOINTS NEWS by John Carroll & team — all the news at 11:30am ET EARLY EDITION by Arsalan Arif — news and links at 7:15am ET ENDPOINTS MANUFACTURING Weekly biopharma manufacturing report ...

News. All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents · All NewsTop NewsBio/Pharma NewsIndustry NewsSupplier NewsEvents. Publications.

Jan 21, 2022 · News. All News Top News Bio/Pharma News Industry News Supplier News Events. Publications. All Publications BioPharm International. Resources. Podcast Series Biopharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers. Webcasts. Subscribe. Enews Magazine.

News stories and articles referencing Biopharma on European Pharmaceutical Review.

News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream/downstream processing, cell culture and regulations.

Jan 17, 2022 · All News Top News Bio/Pharma News Industry News Supplier News Events. Publications. All Publications BioPharm International. Resources. Podcast Series Biopharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers. Webcasts. Subscribe.

2 days ago · ENDPOINTS NEWS by John Carroll & team — all the news at 11:30am ET EARLY EDITION by Arsalan Arif — news and links at 7:15am ET ENDPOINTS MANUFACTURING Weekly biopharma manufacturing report ...

Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.

Read the latest biotechnology articles on biotech industry leaders, emerging biotech companies, FDA decisions, VC deals, and other biotech industry news.

Atara Biotherapeutics has worked on advancing its allogeneic T-cell therapy platform for patients with cancer and autoimmune disease for years, with much of the ...